biofertilizer
Commented by Jens Castner on September 17th, 2026 | 08:50 CEST
From Farm to Supermarket Shelf: MustGrow Biologics, Sprouts and Hain Celestial Fuel the Appetite for Organic
Created and Published on Behalf of MustGrow Biologics Corp.
Healthy, sustainable, organic: the trend toward conscious eating shows no signs of slowing down. Yet the sector has recently disappointed on the stock market. Soaring costs for raw materials and logistics are eating into producers' margins, while inflation is forcing consumers to be more cautious at the checkout. But these lean years can also create opportunities. A closer look at the entire value chain, from the field to the supermarket shelf, reveals three very different cases: MustGrow Biologics, Hain Celestial and Sprouts Farmers Market. A comparison of the trio reveals where analysts see the greatest upside potential.
Read
Commented by Armin Schulz on September 10th, 2026 | 06:50 CEST
Brussels Is Driving the Billion-Dollar Fertilizer Market: Can Bayer, MustGrow Biologics and K+S Benefit?
Created and Published on Behalf of MustGrow Biologics Corp.
Agriculture is in crisis, creating a billion-dollar market that few investors can afford to ignore. Brussels is imposing ever tighter restrictions on chemical crop protection products in Europe, while soils around the world are becoming increasingly depleted. Those still relying on conventional fertilizers today risk falling behind in the long run. Demand is rising for organic crop protection products and fertilizers that deliver high yields while still meeting environmental requirements. Three stocks show how differently investors can profit from the biological revolution in soil health: Bayer, MustGrow Biologics, and K+S.
Read
Commented by Fabian Lorenz on September 9th, 2026 | 07:00 CEST
Evotec Under Pressure! Analysts See Upside Potential - News From MustGrow and Bayer
Created and Published on Behalf of MustGrow Biologics Corp.
Alarm bells are ringing at Evotec. The share price is at risk of slipping below the EUR 3 mark. Even at this seemingly low price level, analysts are notably reluctant to issue "Buy" recommendations. Evotec has, however, announced a research collaboration to develop new T-cell-activating therapeutic approaches for solid tumors. MustGrow's story is now gaining noticeable momentum. The Canadian AgTech company reached profitability in the first half of the year and expects revenue to increase in the second half. In addition, the first milestone payment from Bayer under their licensing agreement has been received. Further payments running into the millions could follow in the coming years and exceed MustGrow's current market capitalization. Analysts see potential for significant upside. Bayer itself has announced an intensive phase of new product launches for its Crop Science division. Analysts recommend buying the stock.
Read
Commented by Nico Popp on August 25th, 2026 | 07:00 CEST
Goodbye to Chemical Pesticides: Bayer Partner MustGrow Biologics Makes Progress – Has Bioceres Overreached?
Created and Published on Behalf of MustGrow Biologics Corp.
Agriculture is at a turning point. Strict environmental regulations are increasingly pushing chemical crop-protection products off the fields. At the same time, the effects of climate change are creating additional challenges. This puts farmers in a difficult position: on the one hand, they need to secure yields, while on the other, they must comply with increasingly stringent regulations. The solution could lie in biological alternatives to conventional chemical pesticides. This market is growing rapidly and opening up opportunities for innovative companies. We take a look at the latest trends and highlight some exciting companies.
Read
Commented by Armin Schulz on July 20th, 2026 | 07:20 CEST
Profit from the Patents and Technological Moats of SAP, MustGrow Biologics, and TSMC
Created and published on behalf of MustGrow Biologics Corp.
In an era where business models can be copied almost as quickly as your morning coffee order, a true competitive advantage no longer comes from good ideas alone. Instead, it is built on the rare kind of technology that cannot easily be replicated—platforms backed by decades of proprietary data, manufacturing processes requiring multi-billion-dollar investments, or patented technologies protected by significant regulatory barriers. Companies that possess these durable competitive moats secure not only margins but entire markets. Three companies embody this approach in completely different ways—and could provide investors with a blueprint for above-average returns. We take a closer look at SAP, MustGrow Biologics, and TSMC.
Read
Commented by Carsten Mainitz on July 15th, 2026 | 08:15 CEST
The Future of Food: Major Opportunities for MustGrow and K+S! What is Next for Evotec After the Sell-Off?
Created and published on behalf of MustGrow Biologics Corp.
The global food supply is undergoing a profound transformation. A growing world population, climate change, and increasingly stringent environmental regulations are creating both challenges and opportunities for companies with the right solutions. Through its focus on biological crop protection and regenerative agriculture, MustGrow is targeting future markets worth billions. Analysts see significant upside potential for the stock. How should investors position themselves now?
Read
Commented by Nico Popp on July 7th, 2026 | 07:15 CEST
This Market Is Growing 17.1% Annually: Bayer and KWS SAAT Rethink Their Strategies – MustGrow Biologics Gains Momentum
Created and published on behalf of MustGrow Biologics Corp.
It is not only drought that is putting pressure on farmers. Regulators are increasingly banning chemical active ingredients that have been used for decades in an effort to protect soils and consumers. Already, 168 countries have significantly restricted or completely banned the use of approximately 568 chemical pesticides. At the same time, the European Union aims to have at least 25% of its agricultural land farmed organically by 2030. As many highly effective products are being phased out, farmers around the world are facing growing challenges. The question of how to maintain crop yields under these changing conditions has become a key concern for industry. This trend is fueling the biopesticides market, which, according to current industry forecasts by Fortune Business Insights, is expected to grow at a compound annual growth rate (CAGR) of 17.1%, reaching USD 40.61 billion by 2034.
Read
Commented by André Will-Laudien on July 1st, 2026 | 06:50 CEST
Here We Go: A Breakthrough for Bayer, Buy Signals for MustGrow and Kraft Heinz
Created and Published on Behalf of MustGrow Biologics Corp.
According to United Nations projections, the world's population is expected to grow to around 9.7 billion people by 2050. The Food and Agriculture Organization (FAO) estimates that this growth can only be managed with significantly more productive and, at the same time, more sustainable farming methods. This is where MustGrow Biologics comes in with biological crop solutions based on natural mustard extracts. And the company's growth story is only just beginning. The sector is gaining short-term momentum now that Bayer has finally received a positive ruling from the US Supreme Court regarding glyphosate. This should allow the Leverkusen-based company's Crop Science division to really take off. At the same time, a powerful structural trend is reshaping the entire agricultural value chain. Natural resources and food must be produced more sustainably and with greater resilience to meet the nutritional needs of a rapidly growing global population. Companies such as Kraft Heinz are responding by leveraging decades of expertise in building resilient agricultural supply chains and climate-adaptive farming systems. These are exciting developments in a sector that is often overlooked in the shadow of high-tech and defence. But the technological trends have long since shifted!
Read